These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24310721)

  • 1. Synthesis and evaluation of (13)N-labelled azo compounds for β-amyloid imaging in mice.
    Gaja V; Gómez-Vallejo V; Puigivila M; Pérez-Campaña C; Martin A; García-Osta A; Calvo-Fernández T; Cuadrado-Tejedor M; Franco R; Llop J
    Mol Imaging Biol; 2014 Aug; 16(4):538-49. PubMed ID: 24310721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
    Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain.
    Fissers J; Waldron AM; De Vijlder T; Van Broeck B; Pemberton DJ; Mercken M; Van Der Veken P; Joossens J; Augustyns K; Dedeurwaerdere S; Stroobants S; Staelens S; Wyffels L
    Mol Imaging Biol; 2016 Aug; 18(4):598-605. PubMed ID: 26846128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
    Yousefi BH; Manook A; Drzezga A; von Reutern B; Schwaiger M; Wester HJ; Henriksen G
    J Med Chem; 2011 Feb; 54(4):949-56. PubMed ID: 21275403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging.
    Syvänen S; Fang XT; Hultqvist G; Meier SR; Lannfelt L; Sehlin D
    Neuroimage; 2017 Mar; 148():55-63. PubMed ID: 28069541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal evaluation of a novel BChE PET tracer as an early
    Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
    Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
    [No Abstract]   [Full Text] [Related]  

  • 10. A convenient synthesis of 13N-labelled azo compounds: a new route for the preparation of amyloid imaging PET probes.
    Gómez-Vallejo V; Borrell JI; Llop J
    Eur J Med Chem; 2010 Nov; 45(11):5318-23. PubMed ID: 20833450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
    Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
    J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
    Cui M; Ono M; Kimura H; Ueda M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Liu B; Saji H
    J Med Chem; 2012 Nov; 55(21):9136-45. PubMed ID: 22690944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
    Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB
    J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
    Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T
    J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice.
    Waldron AM; Wintmolders C; Bottelbergs A; Kelley JB; Schmidt ME; Stroobants S; Langlois X; Staelens S
    Alzheimers Res Ther; 2015 Dec; 7(1):76. PubMed ID: 26666747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.